128 related articles for article (PubMed ID: 11243702)
21. CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency.
van Zelm MC; Smet J; Adams B; Mascart F; Schandené L; Janssen F; Ferster A; Kuo CC; Levy S; van Dongen JJ; van der Burg M
J Clin Invest; 2010 Apr; 120(4):1265-74. PubMed ID: 20237408
[TBL] [Abstract][Full Text] [Related]
22. The role of the CD19/CD21 complex in B cell processing and presentation of complement-tagged antigens.
Cherukuri A; Cheng PC; Pierce SK
J Immunol; 2001 Jul; 167(1):163-72. PubMed ID: 11418645
[TBL] [Abstract][Full Text] [Related]
23. [B cell activated co-receptor].
Ruan X; Zhu LP; Zhang W
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Aug; 24(4):436-9. PubMed ID: 12905672
[TBL] [Abstract][Full Text] [Related]
24. CD21/CD35 in B cell activation.
Carroll MC
Semin Immunol; 1998 Aug; 10(4):279-86. PubMed ID: 9695184
[TBL] [Abstract][Full Text] [Related]
25. Complement's participation in acquired immunity.
Nielsen CH; Leslie RG
J Leukoc Biol; 2002 Aug; 72(2):249-61. PubMed ID: 12149415
[TBL] [Abstract][Full Text] [Related]
26. Growth inhibition of a B cell clone mediated by ligation of IL-4 receptors or membrane IgM.
Bishop GA; Ramirez LM; Koretzky GA
J Immunol; 1993 Apr; 150(7):2565-74. PubMed ID: 8454843
[TBL] [Abstract][Full Text] [Related]
27. The CD19/CD21 signal transduction complex of B lymphocytes.
Tedder TF; Zhou LJ; Engel P
Immunol Today; 1994 Sep; 15(9):437-42. PubMed ID: 7524521
[TBL] [Abstract][Full Text] [Related]
28. Signaling by the CD19/CD21 complex on B cells.
Carter RH; Barrington RA
Curr Dir Autoimmun; 2004; 7():4-32. PubMed ID: 14719373
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of the anti-leukemic activity of cytokine induced killer cells with an anti-CD19 chimeric receptor delivering a 4-1BB-zeta activating signal.
Marin V; Kakuda H; Dander E; Imai C; Campana D; Biondi A; D'Amico G
Exp Hematol; 2007 Sep; 35(9):1388-97. PubMed ID: 17656004
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr Virus and its glycoprotein-350 upregulate IL-6 in human B-lymphocytes via CD21, involving activation of NF-kappaB and different signaling pathways.
D'Addario M; Libermann TA; Xu J; Ahmad A; Menezes J
J Mol Biol; 2001 May; 308(3):501-14. PubMed ID: 11327783
[TBL] [Abstract][Full Text] [Related]
31. B cell signaling is regulated by induced palmitoylation of CD81.
Cherukuri A; Carter RH; Brooks S; Bornmann W; Finn R; Dowd CS; Pierce SK
J Biol Chem; 2004 Jul; 279(30):31973-82. PubMed ID: 15161911
[TBL] [Abstract][Full Text] [Related]
32. Human marginal zone B cells are not an activated B cell subset: strong expression of CD21 as a putative mediator for rapid B cell activation.
Timens W; Boes A; Poppema S
Eur J Immunol; 1989 Nov; 19(11):2163-6. PubMed ID: 2532141
[TBL] [Abstract][Full Text] [Related]
33. Regulation of IgG antibody responses by epitope density and CD21-mediated costimulation.
Jegerlehner A; Storni T; Lipowsky G; Schmid M; Pumpens P; Bachmann MF
Eur J Immunol; 2002 Nov; 32(11):3305-14. PubMed ID: 12555676
[TBL] [Abstract][Full Text] [Related]
34. Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes.
Matsumoto AK; Martin DR; Carter RH; Klickstein LB; Ahearn JM; Fearon DT
J Exp Med; 1993 Oct; 178(4):1407-17. PubMed ID: 7690834
[TBL] [Abstract][Full Text] [Related]
35. The CD19-CR2-TAPA-1 complex, CD45 and signaling by the antigen receptor of B lymphocytes.
Fearon DT
Curr Opin Immunol; 1993 Jun; 5(3):341-8. PubMed ID: 7688513
[TBL] [Abstract][Full Text] [Related]
36. Regulation of TCR-mediated T cell activation by TNF-RII.
Aspalter RM; Eibl MM; Wolf HM
J Leukoc Biol; 2003 Oct; 74(4):572-82. PubMed ID: 12960285
[TBL] [Abstract][Full Text] [Related]
37. Targeting antigen to CD19 on B cells efficiently activates T cells.
Yan J; Wolff MJ; Unternaehrer J; Mellman I; Mamula MJ
Int Immunol; 2005 Jul; 17(7):869-77. PubMed ID: 15967786
[TBL] [Abstract][Full Text] [Related]
38. B cell defects in SLP65/BLNK-deficient mice can be partially corrected by the absence of CD22, an inhibitory coreceptor for BCR signaling.
Gerlach J; Ghosh S; Jumaa H; Reth M; Wienands J; Chan AC; Nitschke L
Eur J Immunol; 2003 Dec; 33(12):3418-26. PubMed ID: 14635051
[TBL] [Abstract][Full Text] [Related]
39. B cell antigen receptor signaling: roles in cell development and disease.
Gauld SB; Dal Porto JM; Cambier JC
Science; 2002 May; 296(5573):1641-2. PubMed ID: 12040177
[TBL] [Abstract][Full Text] [Related]
40. CD45RA and RO isoforms have distinct effects on cytokine- and B-cell-receptor-mediated signalling in human B cells.
Mättö M; Nuutinen UM; Ropponen A; Myllykangas K; Pelkonen J
Scand J Immunol; 2005 Jun; 61(6):520-8. PubMed ID: 15963046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
